Paclitaxel-Coated Balloon for Narrowing of the Airway
(OXYGEN-RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, respectively.
Who Is on the Research Team?
Ryan M Kern, MD
Principal Investigator
Mayo Clinic
Alexander Hillel, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Paclitaxel-Coated Pulmonary Balloon
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
dilate benign stenoses of the airway tree.
dilate benign stenoses of the airway tree.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Airiver Medical, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.